Healthcare

Anatara has developed animal health and human health products based on its Detach technology platform. The following covers the company's background and key investor considerations.

Chimeric is a clinical-stage cell therapy company developing CAR T cell therapies for cancer. The following covers the company's background and key investor considerations.

Osteopore has developed three-dimensional printed bioresorbable medical implants for bone regeneration. The following covers the company's background and key investor considerations.

The company carries a price-to-earnings ratio of 11.43, implying it has generated positive earnings on a trailing twelve-month basis, which is unusual among the smallest companies on this list. The following covers the company's background, current data and the key considerations for investors.

Despite the pharmaceutical name, the company is classified in retail trade, which likely reflects the channel through which it sells its products. The following covers the company's background and the key considerations for investors.

Shares in EchoIQ (ASX:EIQ) drew fresh attention on the ASX after the stock came under pressure by around 7.71% to AU$1.615 in recent ASX trade. A pullback of this kind naturally puts EIQ on the watchlists of active traders and longer-term followers alike. This …

Shares in Dimerix (ASX:DXB) drew trader interest after the stock moved lower by around 6.00% to AU$0.235 in recent ASX trade. Single-session declines like this often invite questions about whether the move reflects company-specific factors or broader market conditions. The following is a general …